Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evidence-based treatment strategies for hypoplastic left heart syndrome: The role of EFNA1/EphA. | Ann Pediatr Cardiol | 2026 | 42819669 | PubTator, text mining | PubMed |
| Cataract GWAS meta-analysis and multi-omics Mendelian randomisation inform disease mechanisms and candidate target prioritisation. | EBioMedicine | 2026 | 42771993 | PubTator, text mining | PubMed |
| Genome-wide association study of estimated glomerular filtration rate using repeated measurements in the Taiwan Biobank. | Kidney Res Clin Pract | 2026 | 42711253 | PubTator, text mining | PubMed |
| Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis. | J Clin Invest | 2026 | 42544586 | PubTator, text mining | PubMed |
| SHED-Exo delivery of miR-708-5p activates PI3K/AKT signaling pathway to alleviate glucocorticoid-induced osteogenic inhibition in BMSCs. | Mol Cell Biochem | 2026 | 42461469 | PubTator, text mining | PubMed |
| Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank. | Front Nephrol | 2026 | 42445298 | PubTator, text mining | PubMed |
| Proteolytic EphA2 fragments cooperatively promote hepatocellular carcinoma progression. | Cell Death Dis | 2026 | 42366206 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal lactate-active epithelial-immune cell crosstalk that reprograms the immune microenvironment in colorectal cancer. | Transl Oncol | 2026 | 42320170 | PubTator, text mining | PubMed |
Corrigendum to "Cross-species single-cell and spatial transcriptomic mapping reveals EFNA1-EPHA4-mediated stem-like epithelial-macrophage crosstalk driving colorectal cancer progression" [Cancer Letters 649 (2026) 218495]. | Cancer Lett | 2026 | 42285780 | PubTator, text mining | PubMed |
| Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer. | PLoS One | 2026 | 42213680 | PubTator, text mining | PubMed |
| Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma. | Transl Cancer Res | 2026 | 42180949 | PubTator, text mining | PubMed |
| Distinct genetic variants from the whole-exome sequencing of syndromic anorectal malformations: A cross-sectional study. | iScience | 2026 | 42058895 | PubTator, text mining | PubMed |
Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation. | PLoS One | 2026 | 42008415 | PubTator, text mining | PubMed |
| Repurposing Diclofenac as an Anticancer Agent: Suppression of Breast Cancer and Progression through EPAS1-EFNA1 Regulation. | Curr Med Chem | 2026 | 41941163 | PubTator, text mining | PubMed |
| Tumor exosomes impact functional hallmarks of cancer. | Cancer Metastasis Rev | 2026 | 41912733 | PubTator, text mining | PubMed |
| Systematic review of ocular and circulatory cytokines linking diabetic retinopathy to kidney disease. | Front Endocrinol (Lausanne) | 2026 | 41890176 | PubTator, text mining | PubMed |
| Identifying prioritization of potential targets for idiopathic pulmonary fibrosis: Proteome-wide Mendelian randomization and colocalization analyses. | Clinics (Sao Paulo) | 2026 | 41855608 | PubTator, text mining | PubMed |
| ScRNA-Seq Deciphers an Autocrine EFNA1-EPHA1 Loop That Reprograms the Microenvironment in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | 41847220 | PubTator, text mining | PubMed |
| Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer. | Cell Death Discov | 2026 | 41844578 | PubTator, text mining | PubMed |
| Integrative Meta-Analysis Identifies Epithelial-Mesenchymal Transition Gene Signatures as Key Determinants of Ovarian Cancer Progression and Treatment Outcome. | Int J Mol Sci | 2026 | 41828380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers